Dr Reddy

DR REDDY NEWS

Wockhardt sells select branded biz units to Dr Reddy’s for Rs 1,850 crore

February 13, 2020 4:30 am

The proposed divestment is 3.8 times of annualised revenue of the business being transferred. This transaction is expected to be completed in May 2020, subject to shareholders, lenders and other requisite approvals under applicable statutes, it said.

BSE Sensex extends gains after Moody's boost on back of Narendra Modi win at hustings

July 07, 2020 9:46 pm

BSE Sensex shot up by 224.11 points, or 0.91 per cent, to trade at 24,587,16.

Seemandhra region may get fillip from division

April 09, 2014 2:26 pm

Present position of industrial progress will become stagnated and limited only to four districts.

Tracking Sensex: top gainers,losers in June quarter

June 29, 2013 12:03 pm

The markets managed to post gains in the quarter despite falling around 2 percent in June.

Retain 'buy' on Dr Reddy's, target R2,400

June 22, 2013 5:23 am

We expect injectable launches to be a key medium-term growth driver for Dr Reddy’s in the US generics business.

Dr Reddy's Laboratories shares gain on generic Zenatane launch

April 01, 2013 10:30 am

Dr Reddy's gains after company said it launched a generic version of Accutane drug.

Lupin,DRL,Sun get nod for generic drug

March 29, 2012 12:43 am

Three Indian drug majors,Lupin,Dr Reddy’s,Sun Pharma have got approvals from the US health regulator to sell generic quetiapine fumarate tablets,used in treating mental disorders,in the US

Students get expert tips on conclusive marketing

November 21, 2011 4:41 am

Business will not happen where you want it to happen,it will only happen where the consumers are,said SCMHRD director K S Subramanium.

JBCPL shareholders approve pharma portfolio sale to Dr Reddys

September 02, 2011 10:30 pm

Shareholders of JBCPL authorised the sale of Russia-CIS prescription products to Dr Reddy.

AstraZeneca,US firm sue Dr Reddy's over pain drug

April 26, 2011 10:43 am

In March,Pozen said Dr Reddy's had filed with the FDA seeking approval to sell its generic version of Vimovo.

Advertisement
Advertisement
Advertisement